137 related articles for article (PubMed ID: 1381590)
1. CSF monoamine metabolites in old age dementias.
Parnetti L; Gaiti A; Reboldi GP; Santucci C; Mecocci P; Brunetti M; Cadini D; Senin U
Mol Chem Neuropathol; 1992; 16(1-2):143-57. PubMed ID: 1381590
[TBL] [Abstract][Full Text] [Related]
2. Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
Bråne G; Gottfries CG; Blennow K; Karlsson I; Lekman A; Parnetti L; Svennerholm L; Wallin A
Alzheimer Dis Assoc Disord; 1989; 3(3):148-56. PubMed ID: 2477044
[TBL] [Abstract][Full Text] [Related]
3. Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry.
Parnetti L; Gottfries J; Karlsson I; Långström G; Gottfries CG; Svennerholm L
Acta Psychiatr Scand; 1987 May; 75(5):542-8. PubMed ID: 2440238
[TBL] [Abstract][Full Text] [Related]
4. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L
Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850
[TBL] [Abstract][Full Text] [Related]
5. Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia.
Wallin A; Blennow K; Edman A; Månsson JE
Int Psychogeriatr; 1996; 8(3):425-36. PubMed ID: 9116178
[TBL] [Abstract][Full Text] [Related]
6. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type.
Tohgi H; Ueno M; Abe T; Takahashi S; Nozaki Y
J Neural Transm Park Dis Dement Sect; 1992; 4(1):69-77. PubMed ID: 1540305
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
Jolkkonen J; Helkala EL; Kutvonen R; Lehtinen M; Riekkinen PJ
Psychoneuroendocrinology; 1989; 14(1-2):89-95. PubMed ID: 2471986
[TBL] [Abstract][Full Text] [Related]
9. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
Nybäck H; Nyman H; Schalling D
Acta Psychiatr Scand; 1987 Dec; 76(6):648-56. PubMed ID: 2450445
[TBL] [Abstract][Full Text] [Related]
11. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
Gibson CJ; Logue M; Growdon JH
Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531
[TBL] [Abstract][Full Text] [Related]
12. Effects of idebenone on monoamine metabolites in cerebrospinal fluid of patients with cerebrovascular dementia.
Kawakami M; Itoh T
Arch Gerontol Geriatr; 1989 May; 8(3):343-53. PubMed ID: 2475076
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features.
Kaye JA; May C; Daly E; Atack JR; Sweeney DJ; Luxenberg JS; Kay AD; Kaufman S; Milstien S; Friedland RP
Neurology; 1988 Apr; 38(4):554-7. PubMed ID: 2451190
[TBL] [Abstract][Full Text] [Related]
14. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
Mann JJ; Stanley M; Neophytides A; de Leon MJ; Ferris SH; Gershon S
Neurobiol Aging; 1981; 2(1):57-60. PubMed ID: 7266742
[TBL] [Abstract][Full Text] [Related]
15. Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments.
Freed DM; Corkin S; Growdon JH; Nissen MJ
Neuropsychologia; 1988; 26(6):895-902. PubMed ID: 2461537
[TBL] [Abstract][Full Text] [Related]
16. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
[TBL] [Abstract][Full Text] [Related]
17. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
[TBL] [Abstract][Full Text] [Related]
18. Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction.
Sheline YI; Miller K; Bardgett ME; Csernansky JG
Am J Geriatr Psychiatry; 1998; 6(2):155-61. PubMed ID: 9581211
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
20. Dementias, psychological tests, and neurotransmitters.
Degrell I; Pék G; Nagy D; Nagy E; Hoyer S
Arch Gerontol Geriatr; 1985 Dec; 4(4):365-71. PubMed ID: 2421656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
